13F-HR filed by Integral Health Asset Management, LLC
Integral Health Asset Management, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 65 holding rows worth $514,778,000.
- Accession
- 0001420506-22-002185
- Filer
- CIK 1773206
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 65 entries on the cover page, a total value of $514,778,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $514,778,000 with VALUE read as thousands by filing date, 13F file number 028-19946. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 450,000 | $24,224,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W905 | COM NEW | 456,300 | $22,108,000 | thousands by filing date | call |
| Elevance Health, Inc. | 036752103 | COM | 40,000 | $18,170,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 225,000 | $17,507,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 350,000 | $16,958,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 300,000 | $16,158,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 185,000 | $15,932,000 | thousands by filing date | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 440,000 | $14,436,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 220,000 | $14,377,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 70,000 | $14,011,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 357,000 | $13,980,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 350,000 | $13,556,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 600,000 | $13,422,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 50,000 | $13,350,000 | thousands by filing date | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 200,000 | $13,336,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 130,000 | $12,398,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 550,000 | $11,913,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 320,000 | $11,411,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 30,000 | $10,196,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 90,000 | $9,559,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 250,000 | $9,505,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 107,000 | $9,070,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 163,000 | $8,183,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 433,000 | $8,123,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 25,000 | $8,084,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 230,000 | $7,832,000 | thousands by filing date | |
| Danaher Corporation | 235851102 | COM | 30,000 | $7,749,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 15,000 | $7,576,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 40,000 | $7,095,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 125,000 | $6,995,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 500,000 | $6,830,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 375,000 | $6,728,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 130,000 | $6,705,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 90,000 | $6,273,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 50,000 | $6,264,000 | thousands by filing date | |
| DAVITA INC COM | 23918K108 | Stock | 75,000 | $6,208,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 93,000 | $6,128,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 25,000 | $5,735,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 30,000 | $5,724,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 340,000 | $5,352,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 70,000 | $4,889,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 150,000 | $4,874,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 70,000 | $4,781,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 100,000 | $4,660,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 200,000 | $4,466,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 150,000 | $4,050,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 195,000 | $3,715,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 300,000 | $3,594,000 | thousands by filing date | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 115,000 | $3,529,000 | thousands by filing date | |
| SI BONE INC | 825704109 | COM | 200,000 | $3,492,000 | thousands by filing date | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 100,000 | $3,491,000 | thousands by filing date | |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | COM | 525,000 | $3,476,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 200,000 | $3,454,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 92,000 | $3,306,000 | thousands by filing date | |
| AMEDISYS INC | 023436108 | COM | 33,000 | $3,194,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 700,000 | $2,954,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 100,000 | $2,828,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 125,000 | $2,090,000 | thousands by filing date | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 130,000 | $1,927,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 30,000 | $1,857,000 | thousands by filing date | |
| CINCOR PHARMA INC | 17240Y109 | COM | 50,000 | $1,641,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 130,000 | $1,357,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 50,000 | $1,051,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 377,000 | $532,000 | thousands by filing date | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 110,000 | $409,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-22-002185 | this filing | 2022-11-14 | acceptance time not in the bulk data set |